SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-311522
Filing Date
2021-10-28
Accepted
2021-10-28 17:20:57
Documents
13
Period of Report
2021-10-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d247612d8k.htm   iXBRL 8-K 36032
2 EX-99.1 d247612dex991.htm EX-99.1 11541
  Complete submission text file 0001193125-21-311522.txt   179494

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kvsa-20211022.xsd EX-101.SCH 2950
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kvsa-20211022_lab.xml EX-101.LAB 18124
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kvsa-20211022_pre.xml EX-101.PRE 11444
6 EXTRACTED XBRL INSTANCE DOCUMENT d247612d8k_htm.xml XML 3369
Mailing Address 2128 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2128 SAND HILL ROAD MENLO PARK CA 94025 650-376-8500
Khosla Ventures Acquisition Co. (Filer) CIK: 0001841873 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40131 | Film No.: 211359532
SIC: 2834 Pharmaceutical Preparations